Holen Sie sich die Stockscreener-App
17.59
1.79%
0.31
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
41.27%
59.12
|
41.85 | 43.73 | 18.17 | 25.26 |
Operating Expenses
|
2.88%
38.01
|
36.94 | 29.72 | 34.47 | 31.04 |
| Benefits Costs and Expenses |
100.00%
-
|
-84.31 | - | - | - |
| Costs And Expenses |
20.60%
38.01
|
47.87 | 29.72 | 34.47 | 31.04 |
| Operating Income/Loss |
330.44%
21.11
|
4.905 | 14.01 | -16.30 | -5.78 |
| Income/Loss From Continuing Operations Before Tax |
53.14%
59.12
|
126.15 | 43.73 | -25.93 | -6.674 |
| Income Tax Expense/Benefit |
90.23%
1.831
|
18.74 | -17.40 | 13.85 | 3.551 |
| Income/Loss From Continuing Operations After Tax |
346.19%
23.50
|
-9.544 | 35.46 | -25.93 | -6.674 |
|
Net Income/Loss
|
346.19%
23.50
|
-9.544 | 35.46 | -25.93 | -6.674 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
31,100%
33.50
|
0.1074 | 33.28 | 33.16 | 32.37 |
| Diluted Average Shares |
2,908%
34.79
|
-1.2391 | 34.78 | 33.16 | 32.37 |
| Basic Earnings Per Share |
341.38%
0.70
|
-0.29 | 1.07 | -0.78 | -0.21 |
| Diluted Earnings Per Share |
342.86%
0.68
|
-0.28 | 1.02 | -0.78 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):